Product Code: GVR-4-68038-062-0
Flea, Tick And Heartworm Products Market Growth & Trends:
The global flea, tick and heartworm products market size is expected to reach USD 10.90 billion by 2030, registering a CAGR of 7.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing an upsurge in developing and launching innovative products. These products can effectively manage parasitic complications in cats & dogs and prove to be a useful parallel option for treatment for pet owners and veterinarians. One such prominent example is flea & tick control collars. These products are just like normal pet collars but contain a specific drug capable of repelling the infestation of fleas, ticks and mosquitoes for some time.
Apart from Seresto by Elanco, other emerging and established players are actively investing in the development of similar collars but utilize novel approaches to enhance infestation control. These launches can also be considered attempts by other companies to capture the market amidst the lawsuit against Seresto Collar. For example, in January 2024, Neogen Corporation launched a collar named Provecta. This collar uses a combination of drugs called deltamethrin and methoprene to inhibit flea and tick growth in dogs and cats. This collar claims to provide six months of protection from fleas, ticks, and mosquitoes.
Furthermore, approvals for injectable products capable of providing long-term animal protection are further intensifying the competitive rivalry. For example, in May 2023, Merck Animal Health received approval for the Bravecto Quantum sale in Australia. This injectable parasiticide can provide over one year of protection against fleas & ticks. Such instances act as catalysts in driving the market by promoting innovative product development that can effectively address the gaps in the prevention & treatment of FTH complications in animals.
Another crucial driver of the demand for these flea, tick and heartworm products is the rising cases of flea and tick infestation in animals worldwide. For example, according to a May 2024 study published in the Veterinary Medicine & Science Journal, the prevalence of fleas and ticks in dogs from the African country of Ethiopia was estimated to be 69.7% and 36.7%, respectively.
Moreover, across the world, in India, the infestation rate of ticks was estimated to be 57.1% in dogs, according to the January 2024 study published in the Acarological Studies Journal. Furthermore, a March 2023 study published in Psyche Journal of Entomology estimated that the prevalence of fleas and ticks in cats from Iran was around 89% and 63%, respectively. This high infestation rate of parasites like fleas and ticks points towards the growing need for effective products to bring this infestation under control, hence boosting market growth.
Flea, Tick And Heartworm Products Market Report Highlights:
- Based on product, the treatment products segment accounted for the largest revenue share of 76.00% in 2023. This segment is further divided into products like spot-on, oral pills/chewables, sprays, liquid solutions, shampoos, etc. This spot-on product took the highest share owing to its ease of access, greater absorption, and effective treatment.
- Based on type, the prescription segment dominated the with a market share of over 60.00% in 2023. Most flea and tick medications doctors prescribe are taken orally, typically as a tasty, chewable tablet or applied topically for ectoparasites like fleas & ticks.
- Based on animal, the canine segment dominated with a share of over 48.00% in 2023 because dogs are the primary species affected by FTH complications, and there are several flea, tick, and heartworm preventative and treatment options available for dogs. The market has grown due to an increasing prevalence of parasite infection in the canine population.
- Based on mode of delivery, the topical segment dominated the market in 2023 due to its advantages over oral flea, tick, and heartworm medications. One of the primary advantages of topical flea treatments is that many are not systemically absorbed, which means they do not penetrate the skin barrier or enter a pet's bloodstream. This may be advantageous for animals with a history of adverse drug reactions or who have not previously responded well to oral flea treatments.
- Based on parasite, the external parasite segment dominated the market in 2023. This is attributable to the high prevalence of external parasites like fleas and ticks among dogs and cats.
- Based on care, the preventive care segment held the dominant revenue share in 2023 and is expected to witness the fastest CAGR over the forecast period. This can be attributed to the fact that veterinarians, as well as animal welfare organizations throughout the world, focus on taking preventive measures for flea, tick and heartworm complications.
- Based on distribution channel, the online segment is estimated to grow the most over the forecast period. This growth is driven by factors such as increasing penetration of online pharmacies in under-developed and developing economies, increasing variety of OTC products, and, most importantly, the convenience of procuring flea, tick and heartworm products.
- In 2023, North America accounted for the largest market share of 39.71%. The number of Americans who own pets is increasing, which is driving up demand for flea, tick and heartworm products. The region's need for FTH products is also anticipated to grow as the incidence of illnesses caused by fleas, ticks, and heartworms in pets rises.
- The Asia Pacific (APAC) market is anticipated to grow at a CAGR of over 8.9% over the forecast period owing to this high transmission rate of vector-borne infections in dogs & cats in the region, and the need for appropriate veterinary medications.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Flea, Tick & Heartworm (FTH) Products Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing Importance of Preventive Care
- 3.2.1.2. Emergence of Novel FTH Products
- 3.2.1.3. Rise in Spread of Heartworm Disease among Animals
- 3.2.1.4. Rise in Awareness Campaigns
- 3.2.1.5. Increasing Cases of Parastitic Infestations
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Lack of Awareness Among Animal Owners
- 3.2.2.2. High Consolidation of the Market
- 3.2.2.3. Risks Associated with some FTH Products
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Flea, Tick & Heartworm (FTH) Products Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitution
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework by Key Countries
- 3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2018-2023
- 3.3.5. Revenue of Key Blockbuster Drugs (2023)
- 3.3.6. Pricing Analysis
- 3.3.7. COVID-19 Impact Analysis
Chapter 4. Flea, Tick & Heartworm (FTH) Products Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Flea, Tick & Heartworm (FTH) Products Market: Product Movement Analysis
- 4.3. Flea, Tick & Heartworm (FTH) Products Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
- 4.4. Diagnostic Products
- 4.4.1. Diagnostic Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Test Kits
- 4.4.2.1. Test Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Consumables
- 4.4.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Treatment Products
- 4.5.1. Treatment Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Spot on
- 4.5.2.1. Spot on Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Oral pills/Chewable
- 4.5.3.1. Oral pills/Chewable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.4. Spray
- 4.5.4.1. Spray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.5. Liquid Solution
- 4.5.5.1. Liquid Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.6. Shampoo
- 4.5.6.1. Shampoo Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.7. Others
- 4.5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Flea, Tick & Heartworm (FTH) Products Market: Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Flea, Tick & Heartworm (FTH) Products Market: Type Movement Analysis
- 5.3. Flea, Tick & Heartworm (FTH) Products Market Size & Trend Analysis, by type, 2018 to 2030 (USD Million)
- 5.4. Prescription
- 5.4.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. OTC
- 5.5.1. OTC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Flea, Tick & Heartworm (FTH) Products Market: Animal Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Flea, Tick & Heartworm (FTH) Products Market: Animal Movement Analysis
- 6.3. Flea, Tick & Heartworm (FTH) Products Market Size & Trend Analysis, by animal, 2018 to 2030 (USD Million)
- 6.4. Canine
- 6.4.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Feline
- 6.5.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Flea, Tick & Heartworm (FTH) Products Market: By Mode of Delivery Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Flea, Tick & Heartworm (FTH) Products Market: By Mode of Delivery Movement Analysis
- 7.3. Flea, Tick & Heartworm (FTH) Products Market Size & Trend Analysis, by mode of delivery, 2018 to 2030 (USD Million)
- 7.3.1. Topical
- 7.3.1.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. Oral
- 7.3.2.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Injectable
- 7.3.3.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Flea, Tick & Heartworm (FTH) Products Market: By Parasite Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Flea, Tick & Heartworm (FTH) Products Market: By Parasite Movement Analysis
- 8.3. Flea, Tick & Heartworm (FTH) Products Market Size & Trend Analysis, by parasite, 2018 to 2030 (USD Million)
- 8.3.1. External Parasite
- 8.3.1.1. External Parasite Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. Internal Parasite
- 8.3.2.1. Internal Parasite Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Flea, Tick & Heartworm (FTH) Products Market: Care Estimates & Trend Analysis
- 9.1. Segment Dashboard
- 9.2. Flea, Tick & Heartworm (FTH) Products Market: Care Movement Analysis
- 9.3. Flea, Tick & Heartworm (FTH) Products Market Size & Trend Analysis, by care, 2018 to 2030 (USD Million)
- 9.4. Preventive Care
- 9.4.1. Preventive Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.5. Therapeutic Care
- 9.5.1. Therapeutic Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Flea, Tick & Heartworm (FTH) Products Market: By Distribution Channel Estimates & Trend Analysis
- 10.1. Segment Dashboard
- 10.2. Flea, Tick & Heartworm (FTH) Products Market: By Distribution Channel Movement Analysis
- 10.3. Flea, Tick & Heartworm (FTH) Products Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
- 10.3.1. Hospital/Clinic Pharmacy
- 10.3.1.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.3.2. Retail Pharmacy
- 10.3.2.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 10.3.3. Online Pharmacy
- 10.3.3.1. Online Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 11. Flea, Tick & Heartworm (FTH) Products Market: Regional Estimates & Trend Analysis
- 11.1. Regional Dashboard
- 11.2. Flea, Tick & Heartworm (FTH) Products Market Share, By Region, 2023 & 2030 (USD Million)
- 11.3. Regional Outlook
- 11.4. North America
- 11.4.1. North America Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.4.2. U.S.
- 11.4.2.1. Key Country Dynamics
- 11.4.2.2. Competition Insights
- 11.4.2.3. U.S. Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.4.3. Canada
- 11.4.3.1. Key Country Dynamics
- 11.4.3.2. Competition Insights
- 11.4.3.3. Canada Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.4.4. Mexico
- 11.4.4.1. Key Country Dynamics
- 11.4.4.2. Competition Insights
- 11.4.4.3. Mexico Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.5. Europe
- 11.5.1. Europe Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.5.2. UK
- 11.5.2.1. Key Country Dynamics
- 11.5.2.2. Competition Insights
- 11.5.2.3. UK Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.5.3. Germany
- 11.5.3.1. Key Country Dynamics
- 11.5.3.2. Competition Insights
- 11.5.3.3. Germany Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.5.4. France
- 11.5.4.1. Key Country Dynamics
- 11.5.4.2. Competition Insights
- 11.5.4.3. France Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.5.5. Italy
- 11.5.5.1. Key Country Dynamics
- 11.5.5.2. Competition Insights
- 11.5.5.3. Italy Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.5.6. Spain
- 11.5.6.1. Key Country Dynamics
- 11.5.6.2. Competition Insights
- 11.5.6.3. Spain Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.5.7. Denmark
- 11.5.7.1. Key Country Dynamics
- 11.5.7.2. Competition Insights
- 11.5.7.3. Denmark Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.5.8. Sweden
- 11.5.8.1. Key Country Dynamics
- 11.5.8.2. Competition Insights
- 11.5.8.3. Sweden Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.5.9. Norway
- 11.5.9.1. Key Country Dynamics
- 11.5.9.2. Competition Insights
- 11.5.9.3. Norway Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.6. Asia Pacific
- 11.6.1. Asia Pacific Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.6.2. Japan
- 11.6.2.1. Key Country Dynamics
- 11.6.2.2. Competition Insights
- 11.6.2.3. Japan Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.6.3. China
- 11.6.3.1. Key Country Dynamics
- 11.6.3.2. Competition Insights
- 11.6.3.3. China Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.6.4. India
- 11.6.4.1. Key Country Dynamics
- 11.6.4.2. Competition Insights
- 11.6.4.3. India Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.6.5. Australia
- 11.6.5.1. Key Country Dynamics
- 11.6.5.2. Competition Insights
- 11.6.5.3. Australia Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.6.6. South Korea
- 11.6.6.1. Key Country Dynamics
- 11.6.6.2. Competition Insights
- 11.6.6.3. South Korea Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.6.7. Thailand
- 11.6.7.1. Key Country Dynamics
- 11.6.7.2. Competition Insights
- 11.6.7.3. Thailand Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.7. Latin America
- 11.7.1. Latin America Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.7.2. Brazil
- 11.7.2.1. Key Country Dynamics
- 11.7.2.2. Competition Insights
- 11.7.2.3. Brazil Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030
- 11.7.3. Argentina
- 11.7.3.1. Key Country Dynamics
- 11.7.3.2. Competition Insights
- 11.7.3.3. Argentina Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.8. Middle East & Africa
- 11.8.1. Middle East & Africa Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.8.2. South Africa
- 11.8.2.1. Key Country Dynamics
- 11.8.2.2. Competition Insights
- 11.8.2.3. South Africa Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.8.3. Saudi Arabia
- 11.8.3.1. Key Country Dynamics
- 11.8.3.2. Competition Insights
- 11.8.3.3. Saudi Arabia Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.8.4. UAE
- 11.8.4.1. Key Country Dynamics
- 11.8.4.2. Competition Insights
- 11.8.4.3. UAE Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 11.8.5. Kuwait
- 11.8.5.1. Key Country Dynamics
- 11.8.5.2. Competition Insights
- 11.8.5.3. Kuwait Flea, Tick & Heartworm (FTH) Products Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 12. Competitive Landscape
- 12.1. Market Participant Categorization
- 12.2. Company Market Position Analysis/ Heap Map Analysis
- 12.3. Company Profiles
- 12.3.1. Zoetis
- 12.3.1.1. Participant's Overview
- 12.3.1.2. Financial Performance
- 12.3.1.3. Product Benchmarking
- 12.3.1.4. Strategic Initiatives
- 12.3.2. Boehringer Ingelheim
- 12.3.2.1. Participant's Overview
- 12.3.2.2. Financial Performance
- 12.3.2.3. Product Benchmarking
- 12.3.2.4. Strategic Initiatives
- 12.3.3. Merck & Co. Inc.
- 12.3.3.1. Participant's Overview
- 12.3.3.2. Financial Performance
- 12.3.3.3. Product Benchmarking
- 12.3.3.4. Strategic Initiatives
- 12.3.4. Virbac
- 12.3.4.1. Participant's Overview
- 12.3.4.2. Financial Performance
- 12.3.4.3. Product Benchmarking
- 12.3.4.4. Strategic Initiatives
- 12.3.5. Elanco Animal Health
- 12.3.5.1. Participant's Overview
- 12.3.5.2. Financial Performance
- 12.3.5.3. Product Benchmarking
- 12.3.5.4. Strategic Initiatives
- 12.3.6. Ceva
- 12.3.6.1. Participant's Overview
- 12.3.6.2. Financial Performance
- 12.3.6.3. Product Benchmarking
- 12.3.6.4. Strategic Initiatives
- 12.3.7. Promika Llc.
- 12.3.7.1. Participant's Overview
- 12.3.7.2. Financial Performance
- 12.3.7.3. Product Benchmarking
- 12.3.7.4. Strategic Initiatives
- 12.3.8. Sergeant's Pet Care Products, Inc.
- 12.3.8.1. Participant's Overview
- 12.3.8.2. Financial Performance
- 12.3.8.3. Product Benchmarking
- 12.3.8.4. Strategic Initiatives
- 12.3.9. Adams
- 12.3.9.1. Participant's Overview
- 12.3.9.2. Financial Performance
- 12.3.9.3. Product Benchmarking
- 12.3.9.4. Strategic Initiatives
- 12.3.10. BioNote Inc.
- 12.3.10.1. Participant's Overview
- 12.3.10.2. Financial Performance
- 12.3.10.3. Product Benchmarking
- 12.3.10.4. Strategic Initiatives
- 12.3.11. Secure Diagnostics Ltd.
- 12.3.11.1. Participant's Overview
- 12.3.11.2. Financial Performance
- 12.3.11.3. Product Benchmarking
- 12.3.11.4. Strategic Initiatives
- 12.3.12. iNtRON Biotechnology
- 12.3.12.1. Participant's Overview
- 12.3.12.2. Financial Performance
- 12.3.12.3. Product Benchmarking
- 12.3.12.4. Strategic Initiatives
- 12.3.13. Biopanda Reagents Ltd.
- 12.3.13.1. Participant's Overview
- 12.3.13.2. Financial Performance
- 12.3.13.3. Product Benchmarking
- 12.3.13.4. Strategic Initiatives
- 12.4. Strategy Mapping
- 12.4.1. Mergers & Acquisitions
- 12.4.2. Partnerships & Collaborations
- 12.4.3. Expansion
- 12.4.4. Product launch
- 12.4.5. Product Approval
- 12.4.6. Others
- 12.5. List of Key Companies
- 12.5.1. List of Manufacturers
- 12.5.2. List of Distributors